FDA June 4, 2024 5:11 pm FDA panel votes against use of MDMA therapy for PTSD A Food and Drug Administration panel voted against the use of MDMA therapy for treatment of post-traumatic stress disorder, NBC Chicago’s Kate Chappell reports. Local 1:49 Man seriously wounded in Lincoln Park shooting 1:59 Chicago-area residents head to stores in last-minute rush ahead of Thanksgiving 2:09 Dispensaries report big sales on ‘Green Wednesday' 2:28 Spotlight on apprenticeships: Career pathways available outside of the classroom 2:20 Harvey businesses file lawsuit against mayor, alleging improper fees